<h3>Purpose/Objective(s)</h3> As a consequence of treatment, brain tumor survivors may experience chronic symptoms, comorbidities, and psychosocial issues that impact their overall well-being, daily functioning, and quality of life. Commonly identified complications include cognitive dysfunction, vasculopathy, endocrinopathy, ophthalmic sequela, ototoxicity, physical disability, sleep disturbance, mood disorder, unemployment, financial toxicity, secondary malignancy, and care partner fatigue. While there are guidelines for childhood survivors of brain tumors, there are no standardized guidelines for screening, monitoring, and managing treatment-related complications for adult brain tumor survivors. This abstract outlines the results of our expert recommendations from a multidisciplinary panel of healthcare professionals for assessing, screening, and providing appropriate interventions during neuro-oncology survivorship to improve quality of life and health outcomes. <h3>Materials/Methods</h3> We examined the Children's Oncology Group Guideline (COG) recommendations as a foundation to establish guidelines for adult brain tumor survivors. The committee focused on intracranial brain tumors. We performed a literature search using PubMed, EMBASE, and CINAHL databases. The committee structured meetings based on the COG guidelines supplemented by the literature available for adult brain tumor complications. While reviewing the literature, experts in radiation oncology, neuropsychology, endocrinology, vascular neurology, otolaryngology, ophthalmology, sleep medicine, and rehabilitation medicine were invited to discuss and provide their perspectives and recommendations on screening and management of adult brain tumor survivors. <h3>Results</h3> Prior work identified common complications among brain tumor survivors include cognitive dysfunction, vasculopathy, endocrinopathy, ophthalmic sequela, ototoxicity, physical disability, sleep disturbance, mood disorder, unemployment, financial toxicity, and secondary malignancy. The Alvord Brain Tumor Center Survivorship Committee recommends routine screening using laboratory testing, subjective assessment of symptoms, and objective evaluations for patients with malignant brain tumors during patient clinical visits to appropriately monitor the complications of brain tumor treatments. <h3>Conclusion</h3> On-going thorough symptom assessment during survivorship is required due to the variability of onset and progressive nature of the medical complications of treatment. Early detection of the described complications optimizes health promotion and maximizes the quality of life. Effective monitoring and treatment should involve collaboration with primary care providers and may require referral to other specialties and support services to provide patient-centered care during neuro-oncology survivorship.
Read full abstract